GeneDx Holdings (WGS) Operating Leases (2022 - 2026)

GeneDx Holdings has disclosed Operating Leases across 5 years of filings, most recently posting $66.3 million for Q1 2026.

• In Q1 2026, Operating Leases rose 10.7% year-over-year to $66.3 million; the TTM figure through Mar 2026 stood at $66.3 million (up 10.7% YoY), while the FY2025 annual figure was $56.0 million, down 12.78% from the prior year.
• Operating Leases improved to $66.3 million in Q1 2026, from $56.0 million in the prior quarter.
• Over the last five years, Operating Leases for WGS reached as high as $66.3 million in Q1 2026 and fell as low as $56.0 million in Q4 2025.
• The 5-year median for Operating Leases is $62.0 million (2024), against an average of $61.4 million.
• Annual changes were most pronounced in 2023 — Operating Leases rose 11.14% — and 2025, when it slipped 12.78%.
• A 5-year view of Operating Leases shows it stood at $60.0 million in 2022, then advanced by 4.87% to $62.9 million in 2023, then grew by 2.09% to $64.3 million in 2024, then retreated by 12.78% to $56.0 million in 2025, then gained by 18.35% to $66.3 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $66.3 million, $56.0 million, and $57.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.